John P Grady

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Multiple Myeloma

Tyrosine Kinase

Top Venues

JCO precision oncology

British journal of cancer

Nature communications

British journal of haematology

Garvan Institute of Medical Research

Newcastle University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Garvan Institute of Medical Research Apr 25 2017

Australia

Senior Software Engineer :: Kinghorn Centre for Clinical Genomics

University of Queensland Diamantina Institute for Cancer Immunology and Metabolic Medicine Aug 29 2016 - Apr 13 2017

Australia

Bioinformatics Officer

Newcastle University Feb 01 2015 - Aug 01 2016

United Kingdom

Faculty Fellow :: Wellcome Trust Centre for Mitochondrial Research

Newcastle University Feb 01 2014 - Feb 01 2015

United Kingdom

Research Associate :: Mitochondrial Research Group

Education History

Newcastle University Sep 01 2010 - Nov 27 2013

United Kingdom

PHD :: Mitochondrial Research Group

Publications

Subotheni Thavaneswaran, Maya Kansara, Frank Lin, David Espinoza, John P Grady, Chee Khoon Lee, Mandy L Ballinger, Lucille Sebastian, Theresa Corpuz, Min Ru Qiu, Piyushkumar Mundra, Charles G Bailey, Ulf Schmitz, John Simes, Anthony M Joshua, David M Thomas
A signal-seeking Phase 2 study of olaparib and durvalumab in advanced solid cancers with homologous recombination repair gene alterations. British journal of cancer (2023)
Subotheni Thavaneswaran, Wei Yen Chan, Ray Asghari, John P Grady, Maegan Deegan, Valerie M Jansen, David M Thomas
Clinical Response to Seribantumab, an Anti-Human Epidermal Growth Factor Receptor-3 Immunoglobulin 2 Monoclonal Antibody, in a Patient With Metastatic Pancreatic Ductal Adenocarcinoma Harboring an NRG1 Fusion. JCO precision oncology 6 (2022)
Ankit Shukla, Thu H M Nguyen, Sarat B Moka, Jonathan J Ellis, John P Grady, Harald Oey, Alexandre S Cristino, Kum Kum Khanna, Dirk P Kroese, Lutz Krause, Eloise Dray, J Lynn Fink, Pascal H G Duijf
Chromosome arm aneuploidies shape tumour evolution and drug response. Nature communications 11 (1) (2020)
Andrew T Hutchinson, Duncan R Hewett, J Lynn Fink, John P Grady, Andrew C W Zannettino
Cutting edge genomics reveal new insights into tumour development, disease progression and therapeutic impacts in multiple myeloma. British journal of haematology 178 (2) (2017)